歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > CytoskeletalSignaling > TRx0237 mesylate

瀏覽歷史

S81261

TRx0237 mesylate

源葉(MedMol) 98%
  • 英文名:
  • Leucomethylene blue (Mesylate)
  • 別名:
  • CAS號(hào):
  • 1236208-20-0
  • 分子式:
  • C18H27N3O6S3
  • 分子量:
  • 477.6185
  • 核磁/質(zhì)譜:
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購(gòu)物車...
源葉(MedMol) S81261-5mg 98% ¥240.00元 5 - - - EA 加入購(gòu)物車
源葉(MedMol) S81261-10mg 98% ¥400.00元 5 - - - EA 加入購(gòu)物車
源葉(MedMol) S81261-25mg 98% ¥800.00元 4 - - - EA 加入購(gòu)物車
源葉(MedMol) S81261-100mg 98% ¥2400.00元 3 - - - EA 加入購(gòu)物車
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說(shuō)明書。
  • 產(chǎn)品描述: TRx 0237 (LMTX) mesylate is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia.
  • 靶點(diǎn): Tau aggregation;BetaAmyloid;?MicrotubuleAssociated
  • 體外研究:
    TRx 0237 (LMTX?) is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia. It is a purified forms of Methylene Blue, an old drug that predates the FDA and is being widely used in Africa for the treatment for malaria as well as for methemoglobinemia and other conditions[2]. An in vitro study showed the ability of TRx 0237 in disrupting PHFs(paired helical filaments) isolated from Alzheimer's Disease brain tissues at the concentration at 0.16 μM。
  • 體內(nèi)研究:
    TRx 0237 dose-dependently rescues the learning impairment and restores behavioral flexibility in a spatial problem-solving water-maze task in L1 (minimum effective dose: 9 mg MT/kg for TRx0237) and correctes motor learning in L66 (effective doses: 4 mg MT/kg). It reduces the number of tau-reactive neurons, particularly in the hippocampus and entorhinal cortex in L1 and in a more widespread manner in L66。
  • 參考文獻(xiàn):
    1. LMTM. THERAPEUTICS overview. 2. Panza F, et al. Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?. Expert Opin Pharmacother. 2016, 17(4):457-61. 3. Gui W, Xu S, Dang Z, et al. In Vitro and in Vivo Effect of Mapk Signal Transduction Pathway Inhibitors on Echinococcus multilocularis[J]. Journal of Parasitology. 2019 Feb;105(1):146-154. 4. Liu Z, Wang F, Tang M, et al. Amyloid β and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A (1) receptor[J]. International journal of molecular medicine. 2019 Jan;43(1):435-442.
  • 溶解性: Soluble  in  DMSO、H2O
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.094 ml 10.469 ml 20.937 ml
    5 mM 0.419 ml 2.094 ml 4.187 ml
    10 mM 0.209 ml 1.047 ml 2.094 ml
    50 mM 0.042 ml 0.209 ml 0.419 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。